SCHEMBL13619374

SCHEMBL13619374

OBc1cc(Cl)cc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.50
▸ CYP3A4 P08684 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ TPMT P51580 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ RECQL P46063 1/20 0.36
▸ ERN1 O75460 2/20 0.35
▸ HTR3E A5X5Y0 2/20 0.35
▸ HTR3B O95264 2/20 0.35
▸ HTR3A P46098 2/20 0.35
▸ HTR3D Q70Z44 2/20 0.35
▸ HTR3C Q8WXA8 2/20 0.35
▸ HPGD P15428 1/20 0.32
▸ IDO1 P14902 1/20 0.30
▸ RXRA P19793 1/20 0.30
▸ RXRB P28702 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12326270 0.77 RAPGEF4 (0.38) TSHRCYP3A4ALDH1A1HPGD
SCHEMBL4215705 0.75 — —
SCHEMBL13418186 0.73 — —
1,3,5-Trichlorobenzene SCHEMBL429512 0.71 — —
SCHEMBL972392 0.69 — —
1,3,5-Trichlorobenzene SCHEMBL29043929 0.67 TSHR (0.89) TSHRCYP3A4TP53TPMTALDH1A1
1,3,5-Trichlorobenzene SCHEMBL28436714 0.67 TSHR (0.89) TSHRCYP3A4TP53TPMTALDH1A1
SCHEMBL1804222 0.65 — —
SCHEMBL15285498 0.65 TSHR (0.44) TSHRCYP3A4TP53TPMTALDH1A1
SCHEMBL14140382 0.64 KMT2A (0.42) TSHRALDH1A1IDO1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111448192-B Process for preparing anthelmintic 4-amino-quinoline-3-carboxamide derivatives 拜耳动物保健有限责任公司 2024-04-12 — — CN disclosed
WO-2019164301-A1 COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME 주식회사 엘지화학 2019-08-29 — — WO disclosed
US-10367149-B2 Organic light-emitting device LG CHEM, LTD. (KR) 2019-07-30 — — US disclosed
WO-2017074052-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2017-05-04 — — WO disclosed
WO-2009140342-A1 GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE SCHERING CORPORATION (US) 2009-11-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10367149-B2 Organic light-emitting device CRY1, PPOX, CRY2 TSHR 3334/4885CYP3A4 155/4885TP53 4286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback